BABY - (recommended to subscribers on 3/8/04 at
$4.10)
BOUGHT
at $4.10 SOLD
at $7.49
On February
26th 2004 Natus Medical, a provider of medical equipment and screeners
used on infants, reported 4th quarter 2003 revenue of $9.9 million, up
29% when compared with the 4th quarter of 2002. Revenue was also up 24%
sequentially and was a record for the company. This followed record
revenue
in the 3rd quarter. Net income was $338,000 or 2 cents per share which
compares to a loss of $2.1 million or 13 cents per share in the 4th
quarter
of 2002. In the 4th quarter of 2003 operating expenses were down while
revenue was up, which led to the company's first profitable quarter
since
it went public. 4th quarter 2003 gross margins were 56.2%, up
sequentially
and from the year ago period.
International
sales comprised 23% of total
revenue in 2003. In the 4th quarter of 2003 international sales were up
35% and sales in the United States were up 27%. For the year 2003 Natus
Medical reported $31.6 million in revenue, up 17% from 2002. For the
1st
half of 2004 the company expects to report a loss of $800,000 - $1.2
million
or 5-7 cents per share. However they expect to report a profit of 1-3
cents
per share for the full year reflecting a stronger second half. Revenue
is expected to be $35-$36 million for 2004.
Natus Medical
has $38 million in cash and
investments or $2.30 per share. Book value is $3.19 per share and the
company
carries no debt. At the current price BABY trades at 2x
sales.
If you are able
to watch the stock I would
buy it if it breaks above $4.40 on at least 100,000 shares or breaks
above
$4.40 after the first half hour of trading (whichever comes
first).
If neither of these criteria are met buy on a drop to $4.10.
UPDATE 3/10/2004 - $4.10 BUY PRICE
TRIGGERED SINCE $4.40 WAS NOT
BROKEN TO THE UPSIDE.
11/04/04 - SOLD AT $7.49 FOR A GAIN OF 83%.
|